DavidJ.WhellanMD

Senior Associate Provost for Clinical Research, Thomas Jefferson University Senior Associate Dean for Clinical Research, Sidney Kimmel Medical College James C. Wilson Professor of Medicine

Join to view full profile

Dr. Whellan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Whellan's full profile

Already have an account?

Office
833 Chestnut St
Suite 900
Philadelphia, PA 19107
Phone+1 215-955-2007

Fax+1 215-503-7420

Summary

Dr. David Whellan is a cardiologist in Philadelphia, PA and is affiliated with Thomas Jefferson University Hospitals. He received his medical degree from Washington University School of Medicine in St. Louis and has been in practice 23 years. He specializes in adult heart disease and is experienced in general cardiology.

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1997 - 2001
University of Pennsylvania Health SystemResidency, Internal Medicine, 1994 - 1997
Washington University in St. Louis School of MedicineClass of 1994

Certifications & Licensure

PA State Medical License 1995 - 2024
PA State Medical License 2004 - 2024
NC State Medical License 1997 - 2005
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure Start of enrollment: 2003 Apr 01
Completed
Phase 3
Extracellular Matrix Marker of Arrhythmia Risk (EMMA) Start of enrollment: 2006 Sep 01
Completed
Optivol Diagnostic Data for Discharge in Heart Failure Start of enrollment: 2006 Dec 01
Completed
Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease Start of enrollment: 2010 Jan 01
Terminated
Phase 3
Comparison of 2 Beta Blocker Drugs on Peripheral Arterial Disease in Patients With High Blood Pressure Start of enrollment: 2011 Aug 01
Completed
Phase 3
Rehabilitation and Exercise Training After Hospitalization Start of enrollment: 2011 Oct 01
Completed
Not Applicable
How the Elderly Live With Pain in Heart Failure Start of enrollment: 2012 Jul 01
Completed
Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF Patients (CONFIRM-HF) Start of enrollment: 2013 Sep 01
Withdrawn
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction Start of enrollment: 2014 Apr 01
Completed
Phase 2
Omega 3 for Treatment of Depression in Patients With Heart Failure Start of enrollment: 2014 May 01
Completed
Phase 3
A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients Start of enrollment: 2014 Sep 01
Completed
Not Applicable
Evaluation of a Novel Technique to Investigate CAS Piezo Electric Sensors Start of enrollment: 2017 Jan 01
Terminated
Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV) Start of enrollment: 2019 Oct 16
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

413 citations
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Kenneth B. Margulies, Adrian F. Hernandez, Margaret M. Redfield, Michael M. Givertz, Guilherme H. Oliveira
JAMA. 2016-08-02
8 citations
Physical Rehabilitation in Older Patients Hospitalized with Acute Heart Failure and Diabetes: Insights from REHAB-HF.
Evan M Murray, David J. Whellan, Haiying Chen, Alain G. Bertoni, Pamela W. Duncan
The American Journal of Medicine. 2021-09-10
6 citations
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Preventi...
Jay L. Goldstein, David J. Whellan, James M. Scheiman, Byron L Cryer, Glenn M. Eisen
Cardiovascular Therapeutics. 2016-04-01

Journal Articles

Original Investigation Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Lawton S Cooper, Ileana L Pina, David J Whellan, Daniel B Mark, Kirkwood F Adams, ScienceDirect
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients with Heart Failure with Preserved Ejection Fraction
Gregory D Lewis, David J Whellan, Martin M LeWinter, Margaret M Redfield, Andrew L Smith, Eugene Braunwald, Michael M Givertz, Adrian F Hernandez, Sanjiv J Shah, Horng..., JAMA
Remote Monitoring of Patients with Heart Failure: A White Paper from the Heart Failure Society of America Scientific Statements Committee
Gregory A Ewald, Amanda R Vest, David J Whellan, Michael R Zile, Michael M Givertz, Journal of Cardiac Failure
Impact of Exercise‐Based Cardiac Rehabilitation in Patients with Heart Failure (ExTraMATCH II) on Mortality and Hospitalisation: An Individual Patient Data Meta‐Analys...
David Whellan, Gloria Y Yeh, European Journal of Heart Failure
Join now to see all

Lectures

Cardiology for the Internist 2019: "The Key Points"
2019 ACP Internal Medicine Meeting, Philadelphia - 4/10/2019

Authored Content

Remote Monitoring of Patients with Heart Failure: A White Paper from the Heart Failure Society of America Scientific Statements CommitteeOctober 2018

Press Mentions

Philly Researchers Are Speeding up the Clinical Research Process with Coronavirus TrialsMay 4th, 2020
Thomas Jefferson University-Based Research: Clinical Trials Under Siege in AmericaSeptember 10th, 2019
Harms and Benefits of Estrogen Therapy Among Women with a Hysterectomy Appear to Depend on ...September 10th, 2019
Join now to see all